A10BH - search results

European Union - English - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance.in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).

Canada - English - Health Canada

trajenta tablet

boehringer ingelheim (canada) ltd ltee - linagliptin - tablet - 5mg - linagliptin 5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors

Canada - English - Health Canada

nesina tablet

takeda canada inc - alogliptin (alogliptin benzoate) - tablet - 6.25mg - alogliptin (alogliptin benzoate) 6.25mg - dipeptidyl peptidase-4 (dpp-4) inhibitors

Canada - English - Health Canada

nesina tablet

takeda canada inc - alogliptin (alogliptin benzoate) - tablet - 12.5mg - alogliptin (alogliptin benzoate) 12.5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors

Canada - English - Health Canada

nesina tablet

takeda canada inc - alogliptin (alogliptin benzoate) - tablet - 25mg - alogliptin (alogliptin benzoate) 25mg - dipeptidyl peptidase-4 (dpp-4) inhibitors